Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.31 USD | +2.87% | +0.11% | -18.55% |
May. 21 | Transcript : Pharming Group N.V. - Shareholder/Analyst Call | |
May. 08 | Transcript : Pharming Group N.V., Q1 2024 Earnings Call, May 08, 2024 |
Sales 2024 * | 266M 289M | Sales 2025 * | 304M 329M | Capitalization | 560M 608M |
---|---|---|---|---|---|
Net income 2024 * | -10M -10.84M | Net income 2025 * | 4M 4.34M | EV / Sales 2024 * | 1.77 x |
Net cash position 2024 * | 87.65M 95.06M | Net cash position 2025 * | 109M 118M | EV / Sales 2025 * | 1.49 x |
P/E ratio 2024 * |
-52
x | P/E ratio 2025 * |
-208
x | Employees | 382 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.66% |
Latest transcript on Pharming Group N.V.
1 day | +2.87% | ||
1 week | +0.11% | ||
Current month | -4.71% | ||
1 month | -10.91% | ||
3 months | -20.77% | ||
6 months | -20.09% | ||
Current year | -18.55% |
Managers | Title | Age | Since |
---|---|---|---|
Sijmen de Vries
CEO | Chief Executive Officer | 65 | 08-10-12 |
Jeroen Wakkerman
DFI | Director of Finance/CFO | 55 | 20-11-15 |
Anurag Relan
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Pykett
BRD | Director/Board Member | 60 | 20-12-10 |
Leonard Kruimer
BRD | Director/Board Member | 66 | 21-05-18 |
Sijmen de Vries
CEO | Chief Executive Officer | 65 | 08-10-12 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 9.31 | +2.87% | 5,404 |
24-05-23 | 9.05 | -2.37% | 1,154 |
24-05-22 | 9.27 | -1.70% | 4,033 |
24-05-21 | 9.43 | +4.78% | 12,262 |
24-05-20 | 9 | -3.23% | 9,951 |
Delayed Quote Nasdaq, May 24, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- PHARM Stock
- PHAR Stock